ABSTRACT
The dystroglycan gene produces two products from a single mRNA, the extracellular alpha-dystroglycan and the transmembrane beta-dystroglycan. The Duchenne muscular dystrophy protein, dystrophin, associates with the muscle membrane via beta-dystroglycan, the WW domain of dystrophin interacting with a PPxY motif in beta-dystroglycan. A panel of four monoclonal antibodies (MANDAG1-4) was produced using the last 16 amino acids of beta-dystroglycan as immunogen. The mAbs recognized a 43 kDa band on Western blots of all cells and tissues tested and stained the sarcolemma in immunohistochemistry of skeletal muscle over a wide range of animal species. A monoclonal antibody (mAb) against the WW domain of dystrophin, MANHINGE4A, produced using a 16-mer synthetic peptide, recognized dystrophin on Western blots and also stained the sarcolemma. We have identified the precise sequences recognized by the mAbs using a phage-displayed random 15-mer peptide library. A 7-amino-acid consensus sequence SPPPYVP involved in binding all four beta-dystroglycan mAbs was identified by sequencing 17 different peptides selected from the library. PPY were the most important residues for three mAbs, but PxxVP were essential residues for a fourth mAb, MANDAG2. By sequencing five different random peptides from the library, the epitope on dystrophin recognized by mAb MANHINGE4A was identified as PWxRA in the first beta-strand of the WW domain, with the W and R residues invariably present. A recent three-dimensional structure confirms that the two epitopes are adjacent in the dystrophin-dystroglycan complex, highlighting the question of how the two interacting motifs can also be accessible to antibodies during immunolocalization in situ.
Subject(s)
Amino Acid Motifs/immunology , Cytoskeletal Proteins/immunology , Dystrophin/metabolism , Epitopes/immunology , Membrane Glycoproteins/immunology , Amino Acid Sequence , Animals , Antibodies, Monoclonal/immunology , Antibody Specificity , Blotting, Western , Cytoskeletal Proteins/metabolism , Dystroglycans , Dystrophin/chemistry , Epitope Mapping , Escherichia coli , Membrane Glycoproteins/metabolism , Mice , Models, Molecular , Molecular Sequence Data , Protein Structure, Tertiary , Sequence Homology, Amino AcidABSTRACT
In the canine model of Duchenne muscular dystrophy in golden retrievers (GRMD), a point mutation within the splice acceptor site of intron 6 leads to deletion of exon 7 from the dystrophin mRNA, and the consequent frameshift causes early termination of translation. We have designed a DNA and RNA chimeric oligonucleotide to induce host cell mismatch repair mechanisms and correct the chromosomal mutation to wild type. Direct skeletal muscle injection of the chimeric oligonucleotide into the cranial tibialis compartment of a six-week-old affected male dog, and subsequent analysis of biopsy and necropsy samples, demonstrated in vivo repair of the GRMD mutation that was sustained for 48 weeks. Reverse transcription-polymerase chain reaction (RT-PCR) analysis of exons 5-10 demonstrated increasing levels of exon 7 inclusion with time. An isolated exon 7-specific dystrophin antibody confirmed synthesis of normal-sized dystrophin product and positive localization to the sarcolemma. Chromosomal repair in muscle tissue was confirmed by restriction fragment length polymorphism (RFLP)-PCR and sequencing the PCR product. This work provides evidence for the long-term repair of a specific dystrophin point mutation in muscle of a live animal using a chimeric oligonucleotide.
Subject(s)
DNA Repair , DNA/metabolism , Dystrophin/genetics , Oligonucleotides/therapeutic use , Point Mutation , RNA/metabolism , Animals , Base Sequence , Blotting, Western , Disease Models, Animal , Dogs , Epitope Mapping , Exons , Frameshift Mutation , Immunohistochemistry , Introns , Male , Molecular Sequence Data , Muscle, Skeletal/metabolism , Muscular Dystrophy, Duchenne/genetics , Muscular Dystrophy, Duchenne/therapy , Polymorphism, Restriction Fragment Length , Reverse Transcriptase Polymerase Chain Reaction , Sarcolemma , Sequence Homology, Nucleic Acid , TemperatureABSTRACT
The spinal muscular atrophy protein, SMN, is a cytoplasmic protein that is also found in distinct nuclear structures called "gems." Gems are closely associated with nuclear coiled bodies and both may have a direct role in snRNP maturation and pre-RNA splicing. There has been some controversy over whether gems and coiled bodies colocalize or form adjacent/independent structures in HeLa and other cultured cells. Using a new panel of antibodies against SMN and antibodies against coilin-p80, a systematic and quantitative study of adult differentiated tissues has shown that gems always colocalize with coiled bodies. In some tissues, a small proportion of coiled bodies (<10%) had no SMN, but independent or adjacent gems were not found. The most striking observation, however, was that many cell types appear to have neither gems nor coiled bodies (e.g., cardiac and smooth muscle, blood vessels, stomach, and spleen) and this expression pattern is conserved across human, rabbit, and pig species. This shows that assembly of distinct nuclear bodies is not essential for RNA splicing and supports the view that they may be storage sites for reserves of essential proteins and snRNPs. Overexpression of SMN in COS-7 cells produced supernumerary nuclear bodies, most of which also contained coilin-p80, confirming the close relationship between gems and coiled bodies. However, when SMN is reduced to very low levels in type I SMA fibroblasts, coiled bodies are still formed. Overall, the data suggest that gem/coiled body formation is not determined by high cytoplasmic SMN concentrations or high metabolic activity alone and that a differentiation-specific factor may control their formation.
Subject(s)
Coiled Bodies/physiology , Nerve Tissue Proteins/metabolism , Animals , Antibodies, Monoclonal , Blotting, Western , COS Cells , Cell Nucleus/metabolism , Cell Nucleus/ultrastructure , Coiled Bodies/metabolism , Coiled Bodies/ultrastructure , Cyclic AMP Response Element-Binding Protein , Electrophoresis, Polyacrylamide Gel , Fibroblasts/metabolism , Fibroblasts/ultrastructure , HeLa Cells , Humans , Mice , Mice, Inbred BALB C , Microscopy, Fluorescence , Muscular Atrophy, Spinal , Nerve Tissue Proteins/immunology , Nuclear Proteins/metabolism , Organ Specificity , RNA-Binding Proteins , Rabbits , SMN Complex Proteins , Skin/cytology , Skin/metabolism , Skin/ultrastructure , SwineSubject(s)
Adenosine Diphosphate Ribose/metabolism , Alkylating Agents/pharmacology , Histones/metabolism , Leukemia L1210/metabolism , Nucleoside Diphosphate Sugars/metabolism , Sulfuric Acid Esters/pharmacology , Sulfuric Acids/pharmacology , Animals , Cell Membrane Permeability/drug effects , Electrophoresis, Polyacrylamide Gel , In Vitro Techniques , MiceABSTRACT
Histone acetyltransferase activity in cell extracts from chick myoblast cultures increases up to 24h of cell culture and then decreases steadily to about 30-40% of the 24h value after 6 to 7 days. The decrease in specific activity is independent of the initial cell density. Histone acetylation in intact cells has also been studied by tritiated-acetate labelling. Most of the radioactivity is found in histones H2b, H3 and H4 when separated on acid-urea gels, and is not prevented by puromycin.